HORSE TIMES Magazine :: THE LEADING EQUESTRIAN MAGAZINE IN THE MIDDLE EAST
Add HorseTimes Egypt's Equestrian Magazine to your Favorites Join HorseTimes Egypt's Equestrian Magazine on Facebook Subscribe to HorseTimes Egypt's Equestrian Magazine on Youtube Follow HorseTimes Egypt's Equestrian Magazine on Google+ Pin HorseTimes Egypt's Equestrian Magazine Photos Follow HorseTimes Egypt's Equestrian Magazine Latest News
HOME PROFILE ADVERTISE SUBSCRIBE LINKS CONTACT

The Leading Equestrian Magazine In The Middle East

Welcome To Horse Times
HORSE TIMES is a complimentary quarterly English-language magazine established in Egypt in 1997. It is the only English language publication in the Middle East dedicated to improving access .. read more..

Horse Times Magazine :: Winter Issue # 52

PUBLISHED WINTER 2016, ISSUE 52 FEATURES:

THE MOROCCO ROYAL TOUR
TRILOGY OF THE CHAMPIONS

THE 9TH SALON DU CHEVAL D’EL JADIDA
CARRIES A MESSAGE OF REVIVAL TO THE TRADITIONAL EQUESTRIAN ART

JUMPER OF THE YEAR
THE STORY OF BERTRAM ALLEN, A YOUNG JOCKEY WITH EXQUISITE SKILLS

GERMANY TAKE..

VIEW MAGAZINE ISSUES HERE >>

Horse Times Weekly Headlines :: Issue # 24

- FEI WORLD CUP™ VAULTING FINAL 2017: ITALY AND GERMANY TAKE HOME MALE, FEMALE AND PAS-DE-DEUX

- CHI ALSHAQAB 2017: SCOTT BRASH SCOTT BRASH PREVAILS AT THE CSI5* GRAND PRIX

- BOYD EXELL WINS HIS SEVENTH FEI WORLD CUP™ DRIVING TITLE

- ISABELL WERTH WINS IN GOTHENBURG

- VON ECKERMANN SNAT..

VIEW HEADLINES ISSUES HERE >>

HORSE TIMES RELEASES A NEW BOOK


ALLTECH FEI WORLD EQUESTRIAN GAMES
NORWAY 2014

Download here >>
NEWS EVENTS HEADLINES ISSUES ARTICLES VIDEOS STREAMING BLOG
HORSE TIMES NEWS DETAILS
>> PREDISOLONE AND LAMINITIS RISK
Date: Wednesday, March 16, 2016
Horse Times Egypt: Equestrian Magazine :News :PREDISOLONE AND LAMINITIS RISK

Equine Veterinary Journal Early View February 2016

 

By Heather Ferguson

 

Does oral prednisolone treatment increase the incidence of acute laminitis?

 

Jordan V.J, Ireland J.L and Rendle D.I

 

There is concern that the use of oral prednisolone in horses and ponies potentially increases the risk of laminitis. This retrospective case-control study set out to determine whether there was evidence to support this. Clinical records from ambulatory practice over a period of 13 years were analysed. Horses that had received treatment with oral prednisolone (total 416) were compared against two time-matched controls (total 814) that had not received prednisolone treatment and had been seen by the same veterinary surgeon before and after the horse which had been given prednisolone. The median age in both groups was 13 years and there was no significant difference in breed or sex distribution between the groups. Overall laminitis incidence rate and laminitis rate during prednisolone treatment were calculated and where more than one episode of laminitis occurred in the same horse, only the first was included.

 

There was no statistically significant difference between prednisolone treated and non-treated groups in overall incidence of laminitis or incidence during the treatment period. In total, there were 62 cases of laminitis, giving an overall incidence of laminitis of 3.19 per 100 horse years at risk. Horses had been treated with prednisolone for a variety of disease conditions and there was no association between reason for treatment and risk of laminitis. In the non-prednisolone treated group, 32 episodes of laminitis occurred over the study period, giving an incidence of 3.46 per 100 horse years at risk.

 

In the prednisolone treated group, 16 laminitis cases occurred, giving an incidence of 2.6 per 100 horse years at risk. Seven of these laminitis episodes occurred during the prednisolone treatment period, giving an incidence of 20.84 per 100 horse years at risk during the period prednisolone was being given. The time at which the laminitic episode occurred in relation to prednisolone treatment was variable (median 34 days after commencement of treatment), with 3 cases developing laminitis more than one month after the end of prednisolone treatment.

 

Of the 16 cases of laminitis in the prednisolone group, 6 were investigated for underlying endocrine disease and all 6 were confirmed to have either pituitary pars intermedia dysfunction (PPID) or equine metabolic syndrome (EMS). There was no significant difference in the prevalance of these endocrine conditions between the treated and non-treated groups, but across both groups horses with PPID or EMS had a significantly higher incidence of laminitis compared with horses without endocrine disease although within the prednisolone group, laminitis rates during treatment were not different in those with and without endocrine disorders. Previous history of laminitis and increasing age were associated with increased risk of laminitis. Of the 15 horses euthanased because of laminitis during the study, 3 were from the prednisolone group and 12 from the control group, with no association between prednisolone treatment and mortality due to laminitis.

 

 

Bottom line:

 

Oral prednisolone treatment did not increase the risk of laminitis in this study.

 

 

--Ends--

COMMENTS




Upcoming Events & Coverages



Olympia Horse Show (13-19 December 2016) - EQUIST (19-21 May 2017)

Copyright 2009 - 2017 © Horse Times. All rights reserved. powered by zanss.com